20–21 Nov 2026
Online Conference
Asia/Karachi timezone

An Integrated Framework for Systematic Validation of TPS-Based Dose Calculation in Radiotherapy

20 Nov 2026, 21:00
5m
Online Conference

Online Conference

Online Conference

Speaker

Warda Syed (Hazara University, Mansehra, Pakistan)

Aim & Purpose

This study aimed to establish an integrated framework for validating TPS-based dose calculations in radiotherapy. The objectives were to assess point-dose accuracy for different photon beam energies, evaluate three-dimensional dose distributions, and verify intensity-modulated radiation therapy (IMRT) plans using patient-specific quality assurance and gamma analysis.

Background

Radiotherapy relies on accurate dose calculations to ensure effective and safe cancer treatment. Treatment Planning Systems (TPS) are essential for calculating radiation dose distributions, but their accuracy must be verified through systematic measurements. Point-dose verification, three-dimensional dose assessment, and patient-specific quality assurance provide complementary methods for evaluating dose calculation accuracy and identifying potential discrepancies in radiotherapy treatment planning.

Discussion (methods + interpretation)

Point-dose verification was performed using a water phantom and ionization chamber for 6 MV and 15 MV photon beams under reference conditions. Three-dimensional dose verification was conducted using the Octavius 4D phantom system and VeriSoft software. Additionally, ten IMRT treatment plans generated in the Varian Eclipse Treatment Planning System using the Anisotropic Analytical Algorithm were evaluated through gamma analysis. Dose differences were assessed by comparing measured and calculated doses. Gamma passing rates were evaluated using 3%/3 mm and 2%/2 mm criteria to investigate agreement between planned and measured dose distributions.

Result

Point-dose verification demonstrated a mean dose difference of 0.63%, while three-dimensional dose verification showed a mean dose difference of 1.34%. The IMRT patient-specific quality assurance results achieved mean gamma passing rates exceeding 96% using 3%/3 mm criteria and 93% using 2%/2 mm criteria. These findings indicate satisfactory agreement between calculated and measured dose distributions across the evaluated verification stages, supporting the usefulness of an integrated approach to radiotherapy dosimetric quality assurance

Email address Wardasyed321@gmail.com
Phone number 03479529980

Author

Warda Syed (Hazara University, Mansehra, Pakistan)

Presentation materials